At present, several oral antidiabetic medications are used for the treatment of T2DM including, -glucosidases inhibitors, biguanides, sulfonylureas, meglitinides, GLP-1 receptor agonists (GLP-1RAs), peroxisome proliferator-activated receptor (PPAR-) agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and sodiumglucose transporter 2 (SGLT2) inhibitors
doi: 10.1172/JCI1349 17 GremlichSPorretAHaniEHCherifDVionnetNFroguelPet al
If youre struggling or considering medication once you stop breastfeeding, speak to your GP about whats safe and suitable for you
Evaluation of glucose profile without any information regarding associated symptoms using continuous glucose monitoring system (CGMS) for 5 days demonstrated that 70% of patients with RYGB ( N = 40) had at least one episode of interstitial glucose level less than 55mg/dl several years after surgery [2]
A possible explanation for the similar effects on weight of both GIP agonism and antagonism is the potential desensitisation of GIP receptors by GIP agonists exposure [57]
